NextTrip (NTRP) S-1/A 14 Feb 17 2016 FY IPO registration (amended) Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Nov. 14, 2016
Document and Entity Information:
Entity Registrant Name	SIGMA LABS, INC.
Document Type	S1
Document Period End Date	Sep. 30, 2016
Trading Symbol	sglb
Amendment Flag	true
Amendment Description	AMENDMENT NO. 1
Entity Central Index Key	788,611
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		6,267,577
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY

Balance Sheets

Balance Sheets - USD ($)	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2014
Current Assets
Cash	$ 137,702	$ 1,539,809	$ 2,962,069
Accounts Receivable, net	119,599	280,222	117,726
Inventory	84,659	20,129	56,175
Prepaid Assets	34,097	38,687	29,986
Total Current Assets	376,057	1,878,847	3,165,956
Other Assets
Property and Equipment, net	609,782	714,754	803,027
Deferred Stock Offering Costs	0	0	95,511
Intangible Assets, net	222,674	167,644	95,847
Investment in Joint Venture	500	9,222	0
Prepaid Stock Compensation	208,848	418,547	0
Total Other Assets	1,041,804	1,310,167	994,385
TOTAL ASSETS	1,417,861	3,189,014	4,160,341
Current Liabilities
Accounts Payable	143,217	38,393	309,698
Accrued Expenses	96,322	71,523	44,652
Total Current Liabilities	239,539	109,916	354,350
TOTAL LIABILITIES	239,539	109,916	354,350
Stockholders' Equity
Preferred Stock, $0.001 par; 10,000,000 shares authorized; None issued and outstanding	0	0	0
Common Stock, $0.001 par; 15,000,000 shares authorized; 6,267,577 and 6,239,073 issued and outstanding at September 30, 2016 and December 31, 2015, respectively	6,268	6,239	6,197
Additional Paid-In Capital	10,668,007	10,636,979	10,411,832
Less Deferred Compensation 32,500 and 70,000 common shares, respectively	0	(401,750)	(744,200)
Retained Earnings (Deficit)	(9,495,953)	(7,564,120)	(5,867,838)
Total Stockholders' Equity	1,178,322	3,079,098	3,805,991
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 1,417,861	$ 3,189,014	$ 4,160,341

Balance Sheets Parenthetical

Balance Sheets Parenthetical - $ / shares	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2014
Parentheticals
Preferred Stock, par value	$ 0.001	$ 0.001	$ 0.001
Preferred Stock, shares authorized	10,000,000	10,000,000	10,000,000
Preferred Stock, shares issued	0	0	0
Preferred Stock, shares outstanding	0	0	0
Common Stock, par value	$ 0.001	$ 0.001	$ 0.001
Common Stock, shares authorized	15,000,000	15,000,000	750,000,000
Common Stock, shares issued	6,267,577	6,239,073	619,741,061
Common Stock, shares outstanding	6,267,577	6,239,073	612,741,061
Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance	0	3,250,000	7,000,000

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014
INCOME
Services	$ 189,951	$ 266,566	$ 642,230	$ 648,515	$ 1,234,810	$ 548,723
Total Revenue	189,951	266,566	642,230	648,515	1,234,810	548,723
COST OF SERVICE REVENUE	69,258	25,250	207,744	138,379	214,004	158,936
GROSS PROFIT	120,693	241,316	434,486	510,136	1,020,806	389,787
EXPENSES
Other General and Administration	437,873	293,187	1,345,576	886,965	1,282,952	1,020,262
Payroll Expense	259,011	191,399	727,494	338,533	585,706	404,054
Non-cash Stock Compensation	105,630	221,500	236,554	478,500	518,438	582,550
Warrant Expense	0	0	0	0	0	1,283,333
Research and Development	37,532	122,517	88,504	206,545	330,554	219,132
Total Expenses	840,046	828,603	2,398,128	1,910,543	2,717,650	3,509,331
OTHER INCOME (EXPENSE)
Interest Income	35	265	288	1,137	1,340	3,464
Interest Expense	0	0	31,626	0	0	0
Loss on Equity-Method Investment in Joint Venture	(3)	(108)	(105)	(108)	(778)	0
Total Other Income (Expense)	32	157	31,809	1,029	562	3,464
INCOME (LOSS) BEFORE INCOME TAXES	(719,320)	(587,130)	(1,931,833)	(1,399,378)	(1,696,282)	(3,116,080)
Current Income Tax Expense	0	0	0	0	0	0
Deferred Income Tax Expense	0	0	0	0	0	0
Net Income (Loss)	$ (719,320)	$ (587,130)	$ (1,931,833)	$ (1,399,378)	$ (1,696,282)	$ (3,116,080)
Loss per Common Share - Basic and Diluted	$ (0.11)	$ (0.09)	$ (0.31)	$ (0.22)	$ 0	$ (0.01)
Weighted Average Number of Shares Outstanding - Basic and Diluted	6,259,349	6,234,834	6,243,642	6,224,939	6,228,108	6,103,447

Statement of Stockholders' Equi

Statement of Stockholders' Equity - USD ($)	Common Stock Shares	Common Stock Amount	Additional Paid in Capital	Deferred Compensation	Retained Earnings (Deficit)	Totals
Balance at Dec. 31, 2013	5,597,661	5,597	4,115,373	(88,900)	(2,751,758)	1,280,312
Shares vested				$ 88,250		$ 88,250
Shares issued for services at prices ranging from $9.40 to $13.60	99,750	100	1,237,750	(743,550)		494,300
Shares issued for cash at a price of $8.00 per share	500,000	500	3,775,376			3,775,876
Costs incurred in association with warrant issuances			$ 1,283,333			$ 1,283,333
Net loss for the year ended December 31, 2014					$ (3,116,080)	$ (3,116,080)
Balance. at Dec. 31, 2014	6,197,411	6,197	10,411,832	(744,200)	(5,867,838)	3,805,991
Shares vested				$ 334,500		$ 334,500
Shares issued for prepaid stock compensation				$ 22,700		$ 22,700
Shares issued for services at a price of $5.30	36,037	36	190,964			191,000
Shares issued for services at a price of $5.90	2,500	2	14,748	(14,750)
Shares issued for services at a price of $6.50	625	1	4,063			4,064
Shares issued for services at a price of $6.15	2,500	3	15,372			15,375
Net loss for the year ended December 31, 2015					$ (1,696,282)	$ (1,696,282)
Balance at Dec. 31, 2015	6,239,073	6,239	10,636,979	(401,750)	(7,564,120)	2,677,348

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014
OPERATING ACTIVITIES
Net Income (Loss)	$ (1,931,833)	$ (1,399,378)	$ (1,696,282)	$ (3,116,080)
Noncash Expenses:
Amortization	6,526	1,731	2,308	2,309
Depreciation	131,879	123,205	166,744	20,340
Stock Compensation	240,756	478,500	518,438	582,550
Impairment of Deferred Stock Offering Costs	0	0	95,511	0
Warrant Expense	0	0	0	1,283,333
Change in assets and liabilities:
(Increase) Decrease in Accounts Receivable	16,623	(55,107)	(157,612)	185,719
Allowance for Doubtful Accounts	0	(4,884)	(4,884)	0
Decrease (Increase) in Inventory	(64,530)	(5,578)	36,046	(55,008)
Decrease (Increase) in Prepaid Assets	4,590	20,709	23,702	(4,912)
(Decrease) Increase in Accounts Payable	104,824	(227,508)	(271,305)	207,073
Customer Deposits	0	62,393	0	0
Increase In Accrued Expenses	24,799	17,024	26,871	6,116
NET CASH PROVIDED (USED) BY OPERATING ACTIVITIES	(1,322,366)	(1,038,993)	(1,259,685)	(888,560)
INVESTING ACTIVITIES
Purchase of Furniture and Equipment	(26,907)	(64,334)	(78,471)	(811,948)
Purchase of Intangible Assets	(61,556)	(11,995)	(74,104)	(27,662)
Investment in Joint Venture	8,617	(10,000)	(10,000)	0
Loss on Investment in Joint Venture.,	105	108	778	0
NET CASH (USED) BY INVESTING ACTIVITIES	(79,741)	(86,221)	(162,575)	(839,610)
FINANCING ACTIVITIES
Proceeds from Sale of Stock Subscriptions	0	0	0	4,000,000
Deferred Stock Offering Costs	0	0	0	(95,511)
Stock Offering Costs	0	0	0	(206,698)
NET CASH PROVIDED BY FINANCING ACTIVITIES	0	0	0	3,697,791
NET CASH (DECREASE) INCREASE FOR PERIOD	(14,002,107)	(1,125,214)	(1,422,260)	1,969,621
CASH AT BEGINNING OF PERIOD	1,539,809	2,962,069	2,962,069	992,448
CASH AT END OF PERIOD	137,702	1,836,855	1,539,809	2,962,069
Cash paid during the period for:
Interest	0	0	0	0
Income Taxes	0	0	0	0
Supplemental Schedule of Noncash Investing and Financing Activities:
Issuance of Common Stock for services	$ 152,265	$ 225,189	$ 0	$ 0

Supplemental Schedule of Noncas

Supplemental Schedule of Noncash Investing and Financing Activities - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Schedule of Noncash Investing and Financing Activities
Shares issued to an officer, a director and two consultants	36,038	0
Shares issued to an officer, a director and two consultants per share	$ 5.30	$ 0
Shares vested relating to the Company's Equity Incentive Plan	30,000	0
Reducing deferred compensation	$ 334,500	$ 0
Shares of stock were issued as prepaid stock compensation in the amount	$ 22,700	$ 0
Shares were issued to an employee	2,500	0
Shares were issued to an employee at per share	$ 5.90	$ 0
Shares were unvested	2,500	0
Shares were issued to an employee.	2,500	0
Shares were issued to an employee per share.	$ 6.15	$ 0
Shares were issued to an employee,	625	0
Shares were issued to an employee per share,	$ 6.50	$ 0
Shares issued to a director	0	15,000
Shares issued to a director at per share	$ 0	$ 9.40
Shares issued to employees1	0	60,000
Shares issued to employees per share1	$ 0	$ 12.90
Shares were vested.	0	15,000
Shares were unvested.	0	45,000
Shares issued for consulting services	0	3,750
Shares issued for consulting services at per share	$ 0	$ 12.60
Purchase shares of common stock were issued in conjunction with the sale of common stock	0	142,593
Purchase shares of common stock were issued to a consultant as part of a stock offering	0	21,875
shares vested relating to the Company's Equity Incentive Plan.	0	19,500
Reducing deferred compensation.	$ 0	$ 66,200
Shares issued to two employees and a director	0	8,500
Shares issued to two employees and a director at per share	$ 0	$ 13.60
Shares issued for consulting services.	0	12,500
Shares issued for consulting services at per share.	$ 0	$ 12.80
Warrants to purchase shares of common stock were issued in conjunction with the sale of common stock	0	20,370
Warrants to purchase shares of common stock were issued to a consultant as part of a stock offering	0	3,125

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Summary of Significant Accounting Policies:
Summary of Significant Accounting Policies		NOTE 1 – Summary of Significant Accounting Policies Nature of Business – B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimately leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and process control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace, defense, oil and gas, bio-medical, and power generation. Basis of Presentation Reclassification Property and Equipment – Fair Value of Financial Instruments . · Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. · Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. · Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement. The carrying amounts reported in the balance sheets for the cash and cash equivalents prepaid stock compensation, receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. Income Taxes – The Company adopted the provisions of ASC Topic No. 740, “Accounting for Income Taxes,” at the date of inception on February 5, 2010. As a result of the implementation of ASC Topic No. 740, the Company recognized no increase in the liability for unrecognized tax benefits. The Company has no tax positions at December 31, 2015 and 2014 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the year ended December 31, 2015, the Company recognized no interest and penalties. The Company had no accruals for interest and penalties at December 31, 2015 or 2014. All tax years starting with 2010 are open for examination. Loss Per Share – Accounts Receivable and Allowance for Doubtful Accounts Long-Lived and Intangible Assets – Recently Enacted Accounting Standards Recent Accounting Standards Updates (“ASU”) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant. Cash Equivalents Concentration of Credit Risk Organization Expenditures Stock Based Compensation Equity instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 505, “Equity Based Payments to Non-Employees.” In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that (i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards Codification. Amortization Accounting Estimates Revenue Recognition – Deferred Stock Offering Costs Inventory Research and Development
Summary of Significant Accounting Policies.	NOTE 1 – Summary of Significant Accounting Policies Nature of Business – B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimately leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and process control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace and defense manufacturing, oil and gas and energy manufacturing, bio-medical manufacturing, automotive manufacturing, and other markets such as firearms and recreational equipment. Basis of Presentation Reclassification Loss Per Share – Recently Enacted Accounting Standards Recent Accounting Standards Updates (“ASU”) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability to the Company or their effect on the financial statements would not have been significant. Accounting Estimates

Stockholders' Equity

Stockholders' Equity	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Stockholders' Equity {1}
Stockholders' Equity		NOTE 2 – Stockholders’ Equity Common Stock As indicated in Note 13 – Subsequent Events (below), (1) effective March 17, 2016, our Amended and Restated Articles of Incorporation were amended pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 filed with the Nevada Secretary of State providing for both a reverse stock split of the outstanding shares of our common stock on a 1-for-100 basis on March 17, 2016 and a corresponding decrease in the number of shares of our common stock that we are authorized to issue and (2) upon the closing of the Company’s public offering of its common stock that is described in the Prospectus of which these financial statements form a part, the Company will amend its Amended and Restated Articles of Incorporation pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 providing for both a reverse stock split of the outstanding shares of our common stock on a 1-for-2 basis and a corresponding decrease in the number of shares of our common stock that we are authorized to issue. All amounts shown for common stock included in these financial statements are presented after giving effect to the March 17, 2016 reverse stock split, but do not give effect to the proposed 1-for-2 reverse stock split. On May 23, 2013, the Company issued 20,000 shares of the Company’s common stock to a consultant as noncash compensation for services to be rendered valued at $45,400 or $2.27 per share. Of these shares, 10,000 (valued at $22,700) vested immediately and 9,607 (valued at $21,808) vested during the year ended December 31, 2015. 393 shares (valued at $892) are vested but unearned by the consultant and are reflected as prepaid assets as of December 31, 2015. In January 2014, the Company issued 437,500 shares of stock to an investor for a total purchase price of $3,500,000. In connection with the purchase and sale of the shares, the Company agreed to issue to the investor a warrant to purchase up to 142,593 shares of the Company’s common stock, at an exercise price of $15.00 per share. The warrant had a term of nine months from the date of issuance (January 10, 2014) and had a fair value of approximately $1,212,037. In May 2014, the term of the warrant was extended by nine months to expire in July 2015 and had a fair market value in excess of the remaining fair market value of the original warrant of approximately $1,283,333. A warrant was also issued as part of the offering to a consultant to purchase up to 21,875 shares of common stock at $8.00 per share, valued at approximately $271,250. That warrant had a term of two years from the date of issuance (January 10, 2014). Offering costs paid from the proceeds of the offering were approximately $199,089. The fair value of the warrant of $1,212,037 was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of nine months, expected volatility of 202%, a risk-free interest rate of 0.09%, and an expected dividend yield of 0%. The fair value of the warrant of $271,250 was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of two years, expected volatility of 201%, a risk-free interest rate of 0.39%, and an expected dividend yield of 0%. The fair value of the new warrant related to the extension of the warrant expiration of $1,283,333 (net) was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of 14 months, expected volatility of 226%, a risk-free interest rate of 0.1%, and an expected dividend yield of 0%. In June 2014, the Company issued 62,500 shares of stock to an investor for a total purchase price of $500,000. In connection with the purchase and sale of the shares, the Company agreed to issue to the investor a warrant to purchase up to 20,370 shares of the Company’s common stock, at an exercise price of $15.00 per share. The warrant had a term of one year from the date of issuance (June 4, 2014) and had a fair value of approximately $132,407. A warrant was also issued as part of the offering to a consultant to purchase up to 3,125 shares of common stock at $8.00 per share, valued at approximately $36,250. That warrant has a term of two years from the date of issuance (June 4, 2014). Offering costs paid from the proceeds of the offering were approximately $25,035. The fair value of the warrant of $132,407 was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of one year, expected volatility of 163%, a risk-free interest rate of 0.1%, and an expected dividend yield of 0%. The fair value of the warrant of $36,250 was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of two years, expected volatility of 287%, a risk-free interest rate of 0.41%, and an expected dividend yield of 0%. During July 2014, the Company issued an aggregate of 60,000 shares of common stock to three employees valued at $12.90 per share or $774,000. Twenty-five percent of each employee’s shares vested immediately upon the grant date, 25% of such shares vested upon the first annual anniversary of each employee’s start date, and 25% of such shares will vest on each of the second and third annual anniversary of each employee’s start date, provided that such employee remains in the Company’s continuous employ through such vesting dates. In November 2014, the Company issued 15,000 shares of stock to a director, subject to restrictions, pursuant to the Company’s 2013 Equity Incentive Plan (the “2013 Plan”). The shares were valued at $9.40 or $141,000. All shares vested during the year ended December 31, 2015. In March 2015, the Company issued 10,000 shares of stock to a director. The Company also issued 5,000 shares of stock to an officer, and an aggregate of 21,038 shares of stock to two consultants, subject to vesting restrictions. The shares were issued pursuant to the 2013 Plan. The shares were valued at $5.30 or $191,000. 33,037 of the shares vested during the year ended December 31, 2015. The remaining 3,001 shares unvested at December 31, 2015 (valued at $15,905) are reflected as prepaid assets. In August 2015, in conjunction with the hiring of Ron Fisher, the Company’s Vice President of Business Development, the Company issued to Mr. Fisher 2,500 shares of common stock, subject to performance-based vesting restrictions. In November 2015, the Company issued 625 shares of common stock to an employee valued at $6.50 per share, or $4,063, and issued 2,500 shares of common stock to an employee valued at $6.15 per share, or $15,375. At December 30, 2015, there were 6,239,073 shares of common stock issued and 6,206,573 outstanding. At December 31, 2014, there were 6,197,411 shares issued and 6,127,411 outstanding, reflecting 32,500 and 70,000 shares respectively issued but unvested shares pursuant to the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) and the 2013 Plan. As of December 31, 2015, an aggregate of 1,500 shares and 170,837 shares of common stock were reserved for issuance under the 2011 Plan and the 2013 Plan, respectively, including 32,500 shares subject to vesting restrictions under the 2013 Plan. Deferred Compensation As described under the Common Stock heading above, during July 2014, the Company issued to three employees an aggregate of 60,000 shares of the Company’s common stock, subject to restrictions, pursuant to the 2013 Plan. Such shares were valued at the fair value of $774,000 or $12.90 per share. This compensation is being expensed over the vesting period. As of December 31, 2015, the balance of unvested compensation cost expected to be recognized is $387,000 (30,000 shares valued at $12.90) and is recorded as a reduction of stockholders’ equity. The unvested compensation is expected to be recognized over the weighted average period of approximately 2 years (through July 2017). As described under the Common Stock heading above, in November 2014, the Company issued 15,000 shares of stock to a director, subject to restrictions, pursuant to the Company’s 2013 Equity Incentive Plan (the “2013 Plan”). The shares were valued at $9.40 or $141,000. All shares vested during the year ended December 31, 2015. As described under the Common Stock heading above, the Company issued 10,000 shares of stock to a director in March 2015. The Company also issued 5,000 shares of stock to an officer, and an aggregate of 21,038 shares of stock to two consultants, subject to vesting restrictions. The shares were issued pursuant to the 2013 Plan. The shares were valued at $5.30 or $191,000. 33,037 of the shares vested during the year ended December 31, 2015. The remaining 3,001 shares unvested at December 31, 2015 (valued at $15,905) are reflected as prepaid assets. As described under the Common Stock heading above, in August 2015, the Company issued 2,500 shares of stock to an employee, subject to performance-based vesting restrictions, pursuant to the Company’s 2013 Equity Incentive Plan (the “2013 Plan”). The shares were valued at $5.90 or $14,750. All shares remained unvested as of December 31, 2015. As of December 31, 2015, the balance of unvested compensation cost expected to be recognized is $401,750 and is recorded as a reduction of stockholders’ equity. The unvested compensation is expected to be recognized over the weighted average period of approximately 2 years (through July, 2017). Preferred Stock The Company is authorized to issue 10,000,000 shares of preferred stock, $0.001 par value. No shares of preferred stock were issued and outstanding at December 31, 2015 and 2014. Stock Options During 2015, the Company granted a total of 51,875 options to three employees with vesting periods ranging from one to four years beginning August 10, 2015. As of December 31, 2015, none of the option grants had vested, and only a nominal amount of compensation cost had been recognized during the year. The weighted average period over which total compensation cost of the options of $306,796 will be recognized is 3.81 years. The weighted average exercise price of the options was $5.94 and the weighted average fair value of the options on the dates of grant was $5.91. The estimated fair value of the options was determined using the Black-Scholls pricing model using the following assumptions: Expected term: 10 years Volatility: 180-184% Dividend yield: 0.00% Risk-free interest rate: 2.24-2.32% Warrants At December 31, 2015, the Company had two outstanding warrants to purchase a total of 25,000 shares of common stock at an exercise price of $8.00 per share. Unless exercised, warrants to purchase 21,875 shares will expire on January 10, 2016 and warrants to purchase 3,125 will expire on June 4, 2016. During the year ending December 31, 2015, a warrant to purchase 20,370 shares of common stock at an exercise price of $15.00 per share as well as a warrant to purchase 142,593 shares of common stock at an exercise price of $15.00 per share expired. No warrants expired during the period ending December 31, 2014.
Stockholders' Equity.	NOTE 2 – Stockholders’ Equity Common Stock Effective March 17, 2016, our Amended and Restated Articles of Incorporation were amended pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 (the “Certificate of Change”) filed with the Nevada Secretary of State. The Certificate of Change provided for both a reverse stock split of the outstanding shares of our common stock on a 1-for-100 basis (the “Reverse Stock Split”), and a corresponding decrease in the number of shares of our common stock that we are authorized to issue (the “Share Decrease”). As a result of the Reverse Stock Split, the number of issued and outstanding shares of our common stock decreased from 622,969,835 pre-Reverse Stock Split shares to 6,229,710 post-Reverse Stock Split shares (after adjustment for any fractional shares). Pursuant to the Share Decrease, the number of authorized shares of our common stock decreased from 750,000,000 to 7,500,000 shares of common stock. All amounts shown for common stock included in these financial statements are presented post-Reverse Stock Split. On April 28, 2016, the Company's Amended and Restated Articles of Incorporation were amended to increase the number of authorized shares of the Company's common stock from 7,500,000 to 15,000,000 shares of common stock. As of September 30, 2016, the Company had 15,000,000 shares of authorized common stock, $0.001 par value per share. In February 2016, the Company issued 625 shares of common stock to a new employee, valued at $4.82 per share, or $3,012. In March 2016, the Company issued 3,080 shares of common stock to a consultant, valued at $4.87 per share, or $14,999. In April 2016, the Company issued 3,529 shares of common stock to a consultant, valued at $4.25 per share, or $15,000. In May 2016, the Company issued 2,459 shares of common stock to a consultant, valued at $3.05 per share, or $7,499. In June 2016, the Company issued 2,515 shares of common stock to a consultant, valued at $2.982 per share, or $7,498. In July 2016, the Company issued 4,167 shares of common stock to a consultant, valued at $3.00 per share, or $12,501. In July 2016, the Company issued 31,000 shares of common stock to an employee, valued at $2.97 per share, or $91,760. As of September 30, 2016, there were 6,267,577 shares of common stock issued and outstanding, including 62,250 issued but unvested shares pursuant to the Company's 2011 Equity Incentive Plan (the “2011 Plan”) and the Company's 2013 Equity Incentive Plan (the “2013 Plan”). As of December 31, 2015, there were 6,239,073 shares of common stock issued and outstanding, including 12,500 and 32,500 issued but unvested shares pursuant to the 2011 Plan and the 2013 Plan. On April 28, 2016, at the Annual Meeting of Stockholders of the Company, the Company's stockholders approved an amendment to the 2013 Plan to increase the number of shares of the Company's common stock reserved for issuance under the 2013 Plan by 638,538 shares of our common stock to a total of 750,000 shares (on a post-Reverse Stock Split basis). As of September 30, 2016, an aggregate of 1,500 shares and 601,712 shares of common stock were reserved for issuance under the 2011 Plan and the 2013 Plan, respectively. Stock Options During 2016, the Company granted a total of 137,375 options to nine employees with vesting periods ranging from three to four years beginning November 17, 2016. As of September 30, 2016, stock option compensation expense of $136,787 was recognized during the nine months ended September 30, 2016 for these options and other options granted in 2015. The weighted average period over which total the compensation cost of the options of $660,500 ($327,504 in 2015) will be recognized is 3.02 years. The weighted average exercise price of all options is $4.21 and the weighted average fair value of the options on the grant dates was $3.23. The estimated fair value of the options was determined using the Black-Scholes pricing model using the following assumptions: Expected term: 5-10 years Volatility: 67.3 - 81.7% Dividend yield: 0.00% Risk-free interest rate: 1.13 - 2.32% Warrants As of September 30, 2016, the Company had no outstanding warrants.

Registration Statement on Form

Registration Statement on Form S-3	12 Months Ended
	Dec. 31, 2015
Registration Statement on Form S-3:
Registration Statement on Form S-3	NOTE 3 – Registration Statement on Form S-3 As previously reported, during September 2014, the Company filed a Registration Statement on Form S-3 with the SEC, which was declared effective by the SEC on December 19, 2014. The Company may offer and sell, from time to time, up to $100,000,000 of securities, including shares of the Company’s common stock and preferred stock, debt securities and warrants, either individually or in units, the terms of which will be described in prospectus supplements filed with the SEC, as applicable. Concurrently with the filing of the Registration Statement, the Company entered into an At The Market Offering Agreement, or sales agreement, with Ascendiant Capital Markets, LLC (“Ascendiant”), pursuant to which the Company may offer and sell from time to time through Ascendiant, acting as sales agent and/or principal, shares of our common stock having an aggregate offering price of up to $25,000,000. We have agreed to pay Ascendiant a commission rate of 3% of the gross sales price per share of any of our shares of common stock sold through Ascendiant, as agent, under the sales agreement. The offer and sale of our shares through Ascendiant will be registered pursuant to the Registration Statement. As of December 31, 2015, no securities have been sold under the Registration Statement. As of December 31, 2015, the Company was not eligible to use the Registration Statement because the aggregate market value of the Company’s outstanding common stock held by non-affiliates of the Company was less than the minimum required by General Institution I.B.1 of Form S-3 (i.e., $75 million).

Continuing Operations

Continuing Operations	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Continuing Operations:
Continuing Operations		NOTE 4 – Continuing Operations The Company has sustained losses and has negative cash flows from operating activities since its inception. However, the Company has had increasing revenues in recent periods. In addition, the Company has raised significant equity capital and is currently developing new product lines to increase future revenues. The Company believes it has adequate working capital and cash to fund operations through 2016, and has entered into significant revenue contracts that are expected to generate cash flow in the near term.
Continuing Operations,	NOTE 3 - Continuing Operations The Company has sustained losses and has negative cash flows from operating activities since its inception. However, the Company has had increasing revenues in recent periods. In addition, the Company has raised significant equity capital and is currently developing new product lines to increase future revenues. The Company believes it has adequate working capital and cash to fund operations through 2016, and has entered into significant revenue contracts that are expected to generate cash flow in the near term.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2015
Income Taxes:
Income Tax Disclosure	NOTE 5 – Income Taxes The Company accounts for income taxes in accordance with ASC Topic No. 740. This standard requires the Company to provide a net deferred tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax accounting methods and any available operating loss or tax credit carryforwards. Income tax returns open for examination by the Internal Revenue Service consist of tax years ended December 31, 2012 through 2014. The Company has available at December 31, 2015, unused operating loss carryforwards of approximately $6,131,324, which may be applied against future taxable income and which expire in various years through 2035. However, if certain substantial changes in the Company’s ownership should occur, there could be an annual limitation on the amount of net operating loss carryforward which can be utilized. The amount of and ultimate realization of the benefits from the operating loss carryforwards for income tax purposes is dependent, in part, upon the tax laws in effect, the future earnings of the Company and other future events, the effects of which cannot be determined. Because of the uncertainty surrounding the realization of the loss carryforwards, the Company has established a valuation allowance equal to the tax effect of the loss carryforwards and other temporary differences of approximately $2,914,526 and $2,255,520 at December 31, 2015 and 2014, respectively, and, therefore, no deferred tax asset has been recognized for the loss carryforwards. The change in the valuation allowance is approximately $659,006 and $1,210,597for the years ended December 31, 2015 and 2014, respectively. Deferred tax assets are comprised of the following: 2015 2014 Deferred tax assets NOL carryover $ 2,382,020 $ 1,723,014 Impairments 33,931 33,931 Warrants 498,575 498,575 Valuation allowance (2,914,526) (2,255,520) Net deferred tax asset $ - $ - The reconciliation of the provision for income taxes computed at the U.S. federal statutory tax rate (34%) to the Company’s effective tax rate for the period ended December 31, 2015 and 2014 is as follows: 2015 2014 Book Loss $ 576,736 $ 1,059,467 State Taxes 82,270 151,130 Deductible differences - - Change in valuation allowance (659,006) (1,210,597) Provision for Income Taxes $ - $ -

Loss Per Share

Loss Per Share	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Earnings Per Share:
Loss Per Share		NOTE 6 – Loss Per Share The following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the periods ended December 31, 2015 and 2014: Year Ended December 31 2015 2014 Loss from continuing operations available to common stockholders (numerator) $ (1,696,282) $ (3,116,080) Weighted average number of common shares outstanding used in loss per share during the period (denominator 6,228,108 6,103,447 Dilutive loss per share was not presented as the Company had no common equivalent shares for all periods presented that would affect the computation of diluted loss per share or its effect is anti-dilutive.
Loss Per Share.	NOTE 4 – Loss Per Share The following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the periods ended September 30, 2016 and 2015: Three Months Ending Nine Months Ending Sept. 30, 2016 Sept. 30, 2015 Sept. 30, 2016 Sept. 30, 2015 Loss from continuing operations available to Common stockholders (numerator) $ (719,320) $ (587,130) $ (1,931,833) $ (1,399,378) Weighted average number of common shares outstanding used in loss per share during the Period (denominator) 6,259,349 6,234,834 6,243,642 6,224,939 Dilutive loss per share was not presented as the Company had no common equivalent shares for all periods presented that would affect the computation of diluted loss per share or its effect is anti-dilutive.

Furniture and Equipment

Furniture and Equipment	12 Months Ended
	Dec. 31, 2015
Furniture and Equipment
Furniture and Equipment	NOTE 7 – Furniture and Equipment The following is a summary of property and equipment, purchased, used and depreciated over a three-year period, less accumulated depreciation, as of December 31, 2015 and 2014: Year Ended December 31, 2015 2014 Property and Equipment $ 966,936 $ 924,319 Less: Accumulated Depreciation (252,182) (121,292) Net Property and Equipment $ 714,754 $ 803,027 Depreciation expense on property and equipment was $166,744 and $20,340 for the years ended December 31, 2015 and 2014, respectively.

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2015
Intangible Assets
Intangible Assets	NOTE 8 – Intangible Assets The Company’s intangible assets consist of Patents, Patent Pending Applications and Customer Contacts. Provisional patent applications are not amortized until a patent has been granted. Once a patent is granted, the Company will amortize the related costs over the estimated useful life of the patent. If a patent application is denied, then the costs will be expensed at that time. The customer contacts were acquired in a business acquisition on December 31, 2011 and were to be amortized over their estimated useful life of three years. The following is a summary of definite-life intangible assets less accumulated amortization as of December 31, 2015 and 2014, respectively: Year Ended December 31, 2015 2014 Provisional Patent Applications $ 137,927 $ 63,823 Patents 39,252 39,252 Customer Contacts 262,009 262,009 Less: Accumulated Amortization (271,544) (269,237) Net Intangible Assets $ 167,644 $ 95,847 Amortization expense on intangible assets was $2,308 and $2,309 for the years ended December 31, 2015 and 2014. The estimated aggregate amortization expense for each of the succeeding years ending December 31 is as follows: 2016 $ 2,309 2017 2,309 2018 2,309 2019 2,309 2020 2,309 Thereafter 18,172 $ 29,717

Commitment and Contingencies

Commitment and Contingencies	12 Months Ended
	Dec. 31, 2015
Commitment and Contingencies:
Commitments and Contingencies Disclosure	NOTE 9 – Commitments and Contingencies Operating Leases

Concentrations

Concentrations	12 Months Ended
	Dec. 31, 2015
Concentrations
Concentrations	NOTE 10 – Concentrations Revenues Customer 2015 2014 A 42.93% 27.03% B 10.06% 0% D 19.57% 29.82% E 3.04% 20.50% F 3.85% 17.7% Accounts Receivable Customer 2015 2014 A 37.30% 50.05% B 14.01% 0% C 27.49% 0% D 7.18% 16.10% E 0% 19.96% F 0% 13.43%

Joint Venture

Joint Venture	12 Months Ended
	Dec. 31, 2015
Joint Venture:
Joint Venture	NOTE 11 Joint Venture As previously reported in our Form 8-K filed with the SEC on July 6, 2015, we entered into an Operating Agreement and Statement of Work with Arete Innovative Solutions LLC (“Arete”). The Operating Agreement and Statement of Work govern the operations of Arete-Sigma LLC (the “Joint Venture”), a joint venture formed by us and Arete for the purpose of pursuing business opportunities related to AM utilizing our EOS M290 or like machines, including enabling and implementing sales and manufacturing transactions. Under the Operating Agreement and Statement of Work, among other matters reported in our Form 8-K and set forth in the Operating Agreement and Statement of Work, (i) each of Sigma and Arete hold a 50% ownership interest in the Joint Venture, and (ii) the Joint Venture is managed by William F. Herman, President of Arete, subject to certain limitations. Based on the Operating Agreement, the Company holds the non-controlling interest in the Joint Venture. Therefore, the Joint Venture has not been consolidated, but rather is accounted for on the equity method of recording investments. During the year ended December 31, 2015, net operations resulted in a loss on the investment of $778. The Company is continuing to pursue business opportunities related to AM utilizing the Company’s EOS M290 or like machines.

Defined Contribution Plan

Defined Contribution Plan	12 Months Ended
	Dec. 31, 2015
Defined Contribution Plan
Defined Contribution Plan	NOTE 12 Defined Contribution Plan In 2014, the Company adopted a qualified 401(K) plan (Plan), in which all employees over the age of 21 may participate. The Company has elected to match 100% of each participant’s contribution up to 3% of salary, and 50% of the next 2% of salary contributed. The Company may also elect, on an annual basis, to make a discretionary contribution to the plan. Company matches and elective contributions vest to participant accounts as follows: 20% after two years of service, and 20% per year thereafter until the participant reaches 6 years of service, at which time, employer contributions vest 100%. The cost of matching contributions were $18,315 in 2015 and $0 in 2014.

Subsequent Events

Subsequent Events	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Subsequent Events
Subsequent Events		NOTE 13 – Subsequent Events The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and determined there are the following items to disclose: On January 10, 2016, a warrant to purchase 21,875 shares of common stock at an exercise price of $8.00 per share expired. In February 2016, the Company issued 625 shares of common stock to a new employee, valued at $4.82 per share, or $3,012.50, and granted to such employee a stock option to purchase 1,875 shares of Company common stock, at an exercise price equal to $4.82 per share, which was the closing market price of the Company’s common stock on February 16, 2016 (i.e., the date of grant), subject to time-based vesting restrictions. The option has a ten In March 2016, the Company granted to two newly hired employees stock options to purchase an aggregate of 20,000 shares of Company common stock, at an exercise price equal to $5.63 per share, which was the closing market price of the Company’s common stock on March 14, 2016 (i.e., the date of grant), subject to time-based vesting restrictions. The options have a ten A 1-for-100 reverse stock split of the Company’s common stock and a corresponding decrease in the number of shares of the Company’s common stock that the Company is authorized to issue was effected on March 17, 2016. The reverse split combined each 100 shares of the Company’s issued and outstanding common stock into one share of common stock. No fractional shares were issued in connection with the reverse split, and any fractional shares resulting from the reverse split were rounded up to the nearest whole share. The reverse split was effective upon the filing of the Certificate of Change Pursuant to Nevada Revised Statutes 78.209 filed with the Nevada Secretary of State effective March 17, 2016. The Company has reflected the effect of the 1-for-100 reverse split of its common stock in these financial statements as if it had occurred at the beginning of the earliest period presented. A 1-for-2 reverse stock split of the Company’s common stock and a corresponding decrease in the number of shares of the Company’s common stock that the Company is authorized to issue will be effected upon the closing of the Company’s public offering of its common stock that is described in the Prospectus of which these financial statements form a part. The reverse split will combine each 2 shares of the Company’s issued and outstanding common stock into 1 share of common stock. No fractional shares will be issued in connection with the reverse split, and any fractional shares resulting from the reverse split will be rounded up to the nearest whole share. The reverse split will be effective upon the filing of the Certificate of Change Pursuant to Nevada Revised Statutes 78.209 with the Nevada Secretary of State. The effects of this pending 1-for-2 reverse stock split has not been reflected in the financial statements or the notes thereto.
Subsequent Events.	NOTE 5 – Subsequent Events Effective October 17, 2016, the Company entered into a Securities Purchase Agreement with two accredited investors (the “Investors”) for the private placement by the Company of Secured Convertibles Notes in the aggregate principal amount of $1,000,000 (the “Notes”) and warrants (the “Warrants”) to purchase up to 160,000 shares (the “Warrant Shares”) of the Company's common stock (“Common Stock”) (subject to adjustment in certain circumstances), for aggregate gross proceeds, before expenses, to the Company of $900,000 (the “Financing Transaction”). The closing of the Financing Transaction (the “Closing”) occurred on October 19, 2016. In connection with the Financing Transaction, the Company entered into a Registration Rights Agreement, dated October 17, 2016, with the Investors (the “Registration Rights Agreement”), pursuant to which the Company agreed to file a registration statement related to the Financing Transaction with the Securities and Exchange Commission (“SEC”) covering the resale of (i) the shares of Common Stock that will be issued to the Investors upon conversion of the Notes (the “Conversion Shares”), and (ii) the Warrant Shares that will be issued to the Investors upon exercise of the Warrants. The Notes are secured by the assets of the Company pursuant to a Security Agreement, dated October 17, 2016, between the Company and the “collateral agent” (as defined in the Notes) for the benefit of itself and each of the Investors. Each Warrant has an initial exercise price equal to the lesser of (i) the final unit price of the Company’s proposed public offering initially filed with the SEC on July 28, 2016, and (ii) 150% of the closing price of the Common Stock as reported by the OTC Markets Group, Inc. on the date of issuance of the Warrants (subject to adjustment as provided therein), which Warrants may be exercised on a cashless basis as provided in the Warrants. A 1-for-2 reverse stock split of the Company’s common stock and a corresponding decrease in the number of shares of the Company’s common stock that the Company is authorized to issue will be effected upon the closing of the Company’s public offering of its common stock that is described in the Prospectus of which these financial statements form a part. The reverse split will combine each 2 shares of the Company’s issued and outstanding common stock into 1 share of common stock. No fractional shares will be issued in connection with the reverse split, and any fractional shares resulting from the reverse split will be rounded up to the nearest whole share. The reverse split will be effective upon the filing of the Certificate of Change Pursuant to Nevada Revised Statutes 78.209 with the Nevada Secretary of State. The Company has not reflected the effect of the proposed 1-for-2 reverse split of its common stock in these financial statements.

Accounting Policies (Policies)

Accounting Policies (Policies)	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Accounting Policies:
Nature of Business,Policy		Nature of Business – B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimately leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and process control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace, defense, oil and gas, bio-medical, and power generation.
Nature of Business.	Nature of Business – B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimately leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and process control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace and defense manufacturing, oil and gas and energy manufacturing, bio-medical manufacturing, automotive manufacturing, and other markets such as firearms and recreational equipment.
Basis of Presentation, Policy		Basis of Presentation
Basis of Presentation.	Basis of Presentation
Reclassification, Policy		Reclassification
Reclassification.	Reclassification
Property, Plant and Equipment, Policy		Property and Equipment –
Fair Value of Financial Instruments, Policy		Fair Value of Financial Instruments . · Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. · Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. · Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement. The carrying amounts reported in the balance sheets for the cash and cash equivalents prepaid stock compensation, receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest.
Income Taxes		Income Taxes – The Company adopted the provisions of ASC Topic No. 740, “Accounting for Income Taxes,” at the date of inception on February 5, 2010. As a result of the implementation of ASC Topic No. 740, the Company recognized no increase in the liability for unrecognized tax benefits. The Company has no tax positions at December 31, 2015 and 2014 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the year ended December 31, 2015, the Company recognized no interest and penalties. The Company had no accruals for interest and penalties at December 31, 2015 or 2014. All tax years starting with 2010 are open for examination.
Loss Per Share , Policy		Loss Per Share –
Loss Per Share Policy.	Loss Per Share –
Accounts Receivable and Allowance for Doubtful Accounts		Accounts Receivable and Allowance for Doubtful Accounts
Long-Lived and Intangible Assets		Long-Lived and Intangible Assets –
Recently Enacted Accounting Standards , Policy		Recently Enacted Accounting Standards Recent Accounting Standards Updates (“ASU”) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant.
Recently Enacted Accounting Standards .	Recently Enacted Accounting Standards Recent Accounting Standards Updates (“ASU”) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability to the Company or their effect on the financial statements would not have been significant.
Cash Equivalents, Policy		Cash Equivalents
Concentration of Credit Risk		Concentration of Credit Risk
Organization Expenditures		Organization Expenditures
Stock Based Compensation		Stock Based Compensation Equity instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 505, “Equity Based Payments to Non-Employees.” In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that (i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards Codification.
Amortization		Amortization
Accounting Estimates , Policy		Accounting Estimates
Accounting Estimates.	Accounting Estimates
Revenue Recognition, Policy		Revenue Recognition –
Deferred Stock Offering Costs		Deferred Stock Offering Costs
Inventory, Policy		Inventory
Research and Development		Research and Development

Schedule of Stock Options (Tabl

Schedule of Stock Options (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Schedule of Stock Options (Tables):
Schedule of Stock Options (Tables)		The estimated fair value of the options was determined using the Black-Scholes pricing model using the following assumptions: Expected term: 5-10 years Volatility: 67.3 - 81.7% Dividend yield: 0.00% Risk-free interest rate: 1.13 - 2.32%
Valuation Assumptions (Tables)	The weighted average exercise price of all options is $4.21 and the weighted average fair value of the options on the grant dates was $3.23. The estimated fair value of the options was determined using the Black-Scholes pricing model using the following assumptions: Expected term: 5-10 years Volatility: 67.3 - 81.7% Dividend yield: 0.00% Risk-free interest rate: 1.13 - 2.32%

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2016
Income Taxes (Tables):
Schedule of Deferred Tax Assets and Liabilities	Deferred tax assets are comprised of the following: 2015 2014 Deferred tax assets NOL carryover $ 2,382,020 $ 1,723,014 Impairments 33,931 33,931 Warrants 498,575 498,575 Valuation allowance (2,914,526) (2,255,520) Net deferred tax asset $ - $ -
Schedule of Effective Income Tax Rate Reconciliation	The reconciliation of the provision for income taxes computed at the U.S. federal statutory tax rate (34%) to the Company’s effective tax rate for the period ended December 31, 2015 and 2014 is as follows: 2015 2014 Book Loss $ 576,736 $ 1,059,467 State Taxes 82,270 151,130 Deductible differences - - Change in valuation allowance (659,006) (1,210,597) Provision for Income Taxes $ - $ -

Schedule of Loss Per Share (Tab

Schedule of Loss Per Share (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Schedule of Loss Per Share (Tables):
Schedule of Loss Per Share	The following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the periods ended September 30, 2016 and 2015: Three Months Ending Nine Months Ending Sept. 30, 2016 Sept. 30, 2015 Sept. 30, 2016 Sept. 30, 2015 Loss from continuing operations available to Common stockholders (numerator) $ (719,320) $ (587,130) $ (1,931,833) $ (1,399,378) Weighted average number of common shares outstanding used in loss per share during the Period (denominator) 6,259,349 6,234,834 6,243,642 6,224,939
Schedule of Earnings Per Share,		The following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the periods ended December 31, 2015 and 2014: Year Ended December 31 2015 2014 Loss from continuing operations available to common stockholders (numerator) $ (1,696,282) $ (3,116,080) Weighted average number of common shares outstanding used in loss per share during the period (denominator 6,228,108 6,103,447

Furniture and Equipment (Tables

Furniture and Equipment (Tables)	9 Months Ended
	Sep. 30, 2016
Furniture and Equipment (Tables):
Furniture and Equipment (Tables)	The following is a summary of property and equipment, purchased, used and depreciated over a three-year period, less accumulated depreciation, as of December 31, 2015 and 2014: Year Ended December 31, 2015 2014 Property and Equipment $ 966,936 $ 924,319 Less: Accumulated Depreciation (252,182) (121,292) Net Property and Equipment $ 714,754 $ 803,027

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2016
Intangible Assets (Tables):
Schedule of Finite-Lived Intangible Assets	The following is a summary of definite-life intangible assets less accumulated amortization as of December 31, 2015 and 2014, respectively: Year Ended December 31, 2015 2014 Provisional Patent Applications $ 137,927 $ 63,823 Patents 39,252 39,252 Customer Contacts 262,009 262,009 Less: Accumulated Amortization (271,544) (269,237) Net Intangible Assets $ 167,644 $ 95,847
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	The estimated aggregate amortization expense for each of the succeeding years ending December 31 is as follows: 2016 $ 2,309 2017 2,309 2018 2,309 2019 2,309 2020 2,309 Thereafter 18,172 $ 29,717

Concentrations (Tables)

Concentrations (Tables)	9 Months Ended
	Sep. 30, 2016
Concentrations (Tables):
Schedule of Revenue by Major Customers by Reporting Segments	The loss of the revenues generated by these customers would have a significant effect on the operations of the Company. Customer 2015 2014 A 42.93% 27.03% B 10.06% 0% D 19.57% 29.82% E 3.04% 20.50% F 3.85% 17.7%
ScheduleOfAccountsReceivableByMajorCustomersByReportingSegmentsTableTextBlock	The Company had the following significant customers who accounted for more than 10% each of the Company’s accounts receivable balance at December 31, 2015 and 2014, respectively. Customer 2015 2014 A 37.30% 50.05% B 14.01% 0% C 27.49% 0% D 7.18% 16.10% E 0% 19.96% F 0% 13.43%

Summary of Significant Accoun28

Summary of Significant Accounting Policies (Details Textual)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2011USD ($)	Sep. 13, 2010$ / shares
Summary Of Significant Accounting Policies Details
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions				100.00%
Number Of Shares Exchanged For Each Share Of Acquired Entity (in shares) | $ / shares				$ 6.67
Finite-Lived Intangible Assets, Useful Life, Maximum			$ 3
Allowance for Doubtful Accounts Receivable, Current	$ 0	$ 4,884
Research and Development Expense, Total	330,554	$ 219,132
Inventory, Raw Materials, Gross	$ 20,129
Finite-Lived Intangible Assets, Useful Life, Maximum	17

Equity Textual 1 (Details)

Equity Textual 1 (Details) - USD ($)	Nov. 30, 2014	Jul. 31, 2014	Jun. 30, 2014	May 31, 2014	Jan. 31, 2014	May 23, 2013
Equity Details
Company issued shares to a consultant as noncash compensation for services to be rendered						20,000
Company issued shares to a consultant as noncash compensation for services to be rendered valed at						$ 45,400
Company issued shares to a consultant as noncash compensation for services to be rendered valed per share						$ 2.27
Company issued vested shares						10,000
Company issued vested shares valued						$ 22,700
Company issued vested shares during the year ended						9,607
Company issued vested shares during the year ended valued						$ 21,808
The remaining shares						393
The remaining shares valued						$ 892
Company issued shares of common stock to three employees		60,000
Company issued shares of common stock to three employees valued at		$ 774,000
Company issued shares of common stock to three employees valued at per share		$ 12.9
Twenty-five percent of each employee's shares vested immediately		25.00%
Company issued shares of stock to a director	15,000
Company issued shares of stock to a director valued at per share	$ 141,000
Increase the number of authorized shares of the common stock from 7,500,000 to	9.4
Company issued shares of stock to an investor			62,500		437,500
Company issued shares of stock to an investor for a total purchase price of			500,000		3,500,000
Company agreed to issue to the investor a warrant to purchase			$ 20,370		$ 142,593
Company agreed to issue to the investor a warrant to purchase at an exercise price per share			$ 15		$ 15
Fair value of warrants			$ 132,407	$ 1,212,037	$ 1,212,037
Fair market value of the original warrant				$ 1,283,333
Warrant issued as part of the offering to a consultant to purchase shares			3,125	21,875
Warrant issued as part of the offering to a consultant to purchase shares per share			$ 8	$ 8
Warrant issued as part of the offering to a consultant to purchase shares valued at			$ 36,250	$ 271,250
Costs paid from the proceeds of the offering			$ 25,035	$ 199,089

Equity Textual 2 (Details)

Equity Textual 2 (Details) - USD ($)	Sep. 30, 2016	Jul. 31, 2016	Jun. 30, 2016	May 31, 2016	Apr. 30, 2016	Apr. 28, 2016	Mar. 31, 2016	Mar. 17, 2016	Feb. 28, 2016	Dec. 31, 2015	Nov. 30, 2015	Mar. 31, 2015	Dec. 31, 2014
Equity Textual 2 Details
Company issued shares of stock to a director												10,000
Issued shares of stock to an officer										5,000		5,000
Aggregate of shares of stock to two consultants												$ 21,038
Shares were valued at												$ 5.3
Shares were valued at per share												$ 191,000
Shares vested during the year												$ 33,037
The remaining shares												3,001
The remaining shares valued												$ 15,905
Company issued shares of common stock to an employee		$ 31,000									$ 625
Company issued shares of common stock to an employee valued at		$ 91,760									$ 4,063
Company issued shares of common stock to an employee at per share		$ 2.97									$ 6.5
Issued shares of common stock to an employee											$ 2,500
Issued shares of common stock to an employee valued at											$ 15,375
Issued shares of common stock to an employee at per share											$ 6.15
Shares of common stock issued	6,267,577									6,239,073			6,197,411
Shares of common stock outstanding										6,206,573			6,127,411
Shares issued										12,500			32,500
Unvested shares pursuant to the Company's 2011 Equity Incentive Plan										$ 32,500			$ 70,000
Shares of common stock were reserved for issuance under the 2011 Plan	62,250									1,500
Shares of common stock were reserved for issuance under the 2013 Plan	$ 638,538									$ 170,837
Shares subject to vesting restrictions under the 2013 Plan	$ 750,000									$ 32,500
Number of issued and outstanding shares of our common stock decreased								$ 622,969,835
Reverse Stock Split shares								$ 6,229,710
Number of authorized shares of our common stock decreased from 750,000,000 to								7,500,000
Increase the number of authorized shares of the common stock from 7,500,000 to						15,000,000
Common stock reserved for issuance under the 2013 Plan by shares						$ 638,538
Shares of our common stock to a total of shares (on a post-Reverse Stock Split basis)						$ 750,000
Company issued shares of common stock to a new employee									625
Company issued shares of common stock to a new employee valued at									$ 3,012
Company issued shares of common stock to a new employee valued at per share									$ 4.82
Company issued shares of common stock to a new consultant		4,167	2,515	2,459	3,529		3,080
Company issued shares of common stock to a consultant valued at		$ 12,501	$ 7,498	$ 7,499	$ 15,000		$ 14,999
Company issued shares of common stock to a consultant valued at per share		$ 3	$ 2.982	$ 3.05	$ 4.25		$ 4.87

Equity Textual 3 (Details)

Equity Textual 3 (Details)	Jun. 30, 2014USD ($)	May 31, 2014USD ($)
Equity Textual 3 Details
Fair value of warrants	$ 132,407	$ 271,250
Expected life maximum	1	2
Expected life minimum	2	9
Expected volatility maximum	287.00%	202.00%
Expected volatility minimum	163.00%	201.00%
Risk-free interest rate maximum	0.10%	0.09%
Risk-free interest rate minimum	0.41%	0.39%
Expected dividend yield	0.00%	0.00%
Warrant expiration		$ 1,283,333
New warrant expected life		14
New warrant expected volatility		226.00%
New warrant risk-free interest rate		0.10%
New warrant expected dividend yield		0.00%

Deferred Compensation (Details)

Deferred Compensation (Details) - USD ($)	Dec. 31, 2015	Aug. 31, 2015	Nov. 30, 2014	Jul. 31, 2014
Deferred Compensation Details
Company issued shares to three employees an aggregate of				60,000
Shares were valued at the fair value				774,000
Shares were valued at the fair value per share				$ 12.90
Balance of unvested compensation cost expected	$ 387,000
Balance of unvested compensation cost expected valued at	$ 30,000
Balance of unvested compensation cost expected per share	$ 12.90
Company issued shares of stock to a director	10,000		15,000
Issued shares of stock to an officer	5,000
Shares of stock to two consultants, subject to vesting restrictions	21,038
Company issued shares of stock to a director valued at	$ 191,000		$ 141,000
Company issued shares of stock to a director at per share	$ 5.30		$ 9.40
Company issued shares vested			33,037
Company issued shares of stock to an employee		2,500
Company issued shares of stock to an employee valued at		$ 5.90
Company issued shares of stock to an employee at per share		$ 14,750
Preferred Stock
Company is authorized to issue shares of preferred stock	10,000,000
Company is authorized to issue shares of preferred stock par value per share	$ 0.001

Stock Options Valuation Assumpt

Stock Options Valuation Assumptions (Details)	Sep. 30, 2016	Dec. 31, 2015
Stock Options Valuation Assumptions Details
Expected term (in years)	10	10
Volatility, Minimum	67.30%	180.00%
Volatility, Maximum	81.70%	184.00%
Dividend yield	0.00%	0.00%
Risk-free interest rate, Minimum	1.13%	2.24%
Risk-free interest rate, Maximum	2.32%	2.32%

Stock Options (Details)

Stock Options (Details)	Sep. 30, 2016USD ($)$ / sharesshares	Dec. 31, 2015$ / sharesshares
Stock Options Details
Company granted a total of options | shares	137,375	51,875
Compensation cost of the options | $	$ 136,787
Total compensation cost of the options | shares	660,500	306,796
Total compensation cost of the options will be recognized in years	3.02	3.81
Weighted average exercise price of the options | $ / shares	$ 4.21	$ 5.94
Weighted average fair value of the options on the dates of grant | $ / shares	$ 3.23	$ 5.91

Warrants (Details)

Warrants (Details) - $ / shares	3 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Warrants Details
Warrant remaining to purchase a total shares of common stock	21,875	25,000
Warrant remaining to purchase a total shares of common stock at an exercise price per share	$ 8	$ 8
Warrant to purchase shares of common stock		21,875
Warrant to purchase shares will expire on June 4, 2016		3,125
Warrant to purchase shares of common stock	3,125	20,370
Warrant to purchase shares of common stock at an exercise price per share	$ 8	$ 15
Warrant to purchase shares of common stock		142,593
Warrant to purchase shares of common stock at an exercise price per share		$ 15

Registration Statement on For36

Registration Statement on Form S-3 (Details Textual)	12 Months Ended
	Dec. 31, 2015USD ($)
Registration Statement on Form S-3 Details
Maximum Securities Available for Offering As Per Registration Statement	$ 100,000,000
Maximum Amount of Offering Price As Per Registration Statement	$ 25,000,000
Percentage Of Commission On Gross Sales Price Per Share	3.00%
Outstanding Common Stock Held by Non Affiliates Aggregate Market Value	$ 75,000,000

Income Taxes (Details)

Income Taxes (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Deferred tax assets:
NOL carryover	$ 2,382,020	$ 1,723,014
Impairments	33,931	33,931
Warrants	498,575	498,575
Valuation allowance	(2,914,526)	$ (2,255,520)
Net deferred tax asset	$ 0

Reconciliation of provision for

Reconciliation of provision for income taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Reconciliation of the provision for income taxes Details
Book Loss	$ 576,736	$ 1,059,467
State Taxes	82,270	151,130
Deductible differences		0
Change in valuation allowance	(659,006)	$ (1,210,597)
Provision for Income Taxes	$ 0

Operating loss carryforwards (D

Operating loss carryforwards (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Operating Loss Carryforwards Details
Operating Loss Carryforwards	$ 6,131,324
Deferred Tax Assets, Valuation Allowance	2,914,526	$ 2,255,520
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	$ 659,006	$ 1,210,597
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%	34.00%

Loss Per Share (Details)

Loss Per Share (Details) - shares	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014
Loss Per Share Details
Loss from continuing Operations available to Common stockholders (numerator)	(719,320)	(587,130)	(1,931,833)	(1,399,378)	(1,696,282)	(3,116,080)
Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)	6,259,349	6,234,834	6,243,642	6,224,939	6,228,108	6,103,447

Furniture and Equipment (Detail

Furniture and Equipment (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment Details
Property and Equipment	$ 966,936	$ 924,319
Less: Accumulated Depreciation	(252,182)	(121,292)
Net Property and Equipment	$ 714,754	$ 803,027

Furniture and Equipment (Deta42

Furniture and Equipment (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Furniture and Equipment Details
Depreciation expense on property and equipment	$ 166,744	$ 20,340

Intangible Assets (Details)

Intangible Assets (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets Details
Provisional Patent Applications	$ 137,927	$ 63,823
Patents	39,252	39,252
Customer Contacts	262,009	262,009
Less: Accumulated Amortization	(271,544)	(269,237)
Net Intangible Assets	$ 167,644	$ 95,847

Amortization of Intangible Asse

Amortization of Intangible Assets (Details)	12 Months Ended
	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Amortization of Intangible Assets Details
Finite-Lived Intangible Asset, Useful Life	3
Amortization of Intangible Assets	$ 2,308	$ 2,309

Amortization expense (Details)

Amortization expense (Details)	Dec. 31, 2015USD ($)
Amortization expense Details
Amortization expense for 2016	$ 2,309
Amortization expense for 2017	2,309
Amortization expense for 2018	2,309
Amortization expense for 2019	2,309
Amortization expense for 2020	2,309
Amortization expense for Thereafter	18,172
Amortization expense Total	$ 29,717

Commitments and Contingencies (

Commitments and Contingencies (Details Textual)	12 Months Ended
	Dec. 31, 2015USD ($)
Commitments and Contingencies Details
Operating Leases, Rent Expense	$ 49,637
Operating Leases, Future Minimum Payments Receivable, Total	$ 39,100

Concentrations (Details)

Concentrations (Details)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Concentrations Details
Concentrations Customer A	42.93%	27.03%
Concentrations Customer B	10.06%	0.00%
Concentrations Customer D	19.57%	29.82%
Concentrations Customer E	3.04%	20.50%
Concentrations Customer F	3.85%	17.70%

Concentrations Accounts Receiva

Concentrations Accounts Receivable (Details)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Concentrations Accounts Receivable Details
Concentrations Accounts Receivable Customer A	37.30%	50.05%
Concentrations Accounts Receivable Customer B	14.01%	0.00%
Concentrations Accounts Receivable Customer C	27.49%	0.00%
Concentrations Accounts Receivable Customer D	7.18%	16.10%
Concentrations Accounts Receivable Customer E	0.00%	19.96%
Concentrations Accounts Receivable Customer F	0.00%	13.43%

Joint Venture (Details Textual)

Joint Venture (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Loss on Investment in Joint Venture Details
Corporate Joint Venture	$ (778)	$ 0
Equity Method Investment, Ownership Percentage	50.00%

Defined Contribution Plan (Deta

Defined Contribution Plan (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Defined Contribution Plan Details
Defined Contribution Plan, Employer Matching Contribution, Percent of Match	100.00%
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent	3.00%
Defined Contribution Plan, Employer Matching Contribution, Percent of Match	50.00%
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent	2.00%
Defined Contribution Plan, Cost Recognized	$ 18,315	$ 0

Subsequent Events (Details Text

Subsequent Events (Details Textual)	Oct. 17, 2016USD ($)shares	Jul. 22, 2016USD ($)$ / sharesshares	Mar. 31, 2016$ / sharesshares	Feb. 29, 2016$ / sharesshares	Jan. 10, 2016$ / sharesshares
Subsequent Event Details
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares					$ 8
Class of Warrant or Right, Number of Securities Called by Warrants or Rights					2,187,500
Company issued Shares of common stock to a new employee				62,500
Share Price | $ / shares				$ 4.82
Sale of Stock, Price Per Share | $ / shares			$ 5.63	$ 4.82
Stock Issued During Period, Value, Share-Based Compensation, Gross				3,012.5
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				187,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			2,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term			10
Company issued shares of common stock, subject to restrictions, to a new employee		31,000
Company issued shares of common stock, subject to restrictions, to a new employee valued at | $		$ 91,760
Company issued shares of common stock, subject to restrictions, to a new employee valued at per share | $ / shares		$ 2.96
Company of Secured Convertibles Notes in the aggregate principal amount | $	$ 1,000,000
Warrants to purchase up to shares	160,000
Company's common stock for aggregate gross proceeds | $	$ 900,000